Ieq Capital LLC Invests $541,000 in Maximus, Inc. (NYSE:MMS)

Ieq Capital LLC acquired a new stake in Maximus, Inc. (NYSE:MMS) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,245 shares of the health services provider’s stock, valued at approximately $541,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nordea Investment Management AB bought a new position in shares of Maximus during the fourth quarter valued at approximately $4,618,000. Fort Washington Investment Advisors Inc. OH lifted its position in Maximus by 39.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock worth $22,132,000 after purchasing an additional 83,390 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Maximus in the fourth quarter worth approximately $1,113,000. Versor Investments LP lifted its position in Maximus by 213.5% in the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock worth $792,000 after purchasing an additional 5,789 shares during the period. Finally, Legato Capital Management LLC increased its holdings in shares of Maximus by 33.9% in the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider’s stock valued at $2,399,000 after buying an additional 8,138 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Trading Down 1.6 %

Shares of NYSE:MMS opened at $66.68 on Thursday. The stock has a market capitalization of $3.77 billion, a PE ratio of 14.34 and a beta of 0.72. Maximus, Inc. has a 1 year low of $64.53 and a 1 year high of $93.97. The firm has a fifty day moving average price of $73.57 and a 200 day moving average price of $81.24. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.80%. Maximus’s dividend payout ratio (DPR) is 25.81%.

Wall Street Analyst Weigh In

Several research firms have issued reports on MMS. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Insider Activity at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Bruce Caswell purchased 3,500 shares of the stock in a transaction on Tuesday, December 17th. The stock was bought at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the transaction, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 7,063 shares of company stock worth $502,017. 1.60% of the stock is owned by corporate insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.